Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PrimaCare is a prescription prenatal and postnatal multivitamin, mineral, and essential fatty acid supplement marketed by Avion Pharmaceuticals. Formulated as a softgel capsule, it is indicated for improving the nutritional status of women throughout the stages of pregnancy, including the prenatal, postnatal, and lactation periods. The product contains a comprehensive array of nutrients, notably 1 mg of folic acid to reduce the risk of neural tube defects, iron (in forms such as carbonyl iron and Sumalate) to support hematopoiesis, and a blend of omega-3 fatty acids including docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) for fetal brain and eye development. As a multi-ingredient nutritional supplement, PrimaCare does not target a single biological pathway but rather provides the necessary substrates for various physiological processes essential for maternal and fetal well-being.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PrimaCare.